ITGA2 and myeloproliferative neoplasm: In the case of human platelet antigen (HPA5), a significant difference was observed in the genotype frequency between patients with MPN with and without vascular events (p = 0.03) with a protective role of HPA5 b allele for patients with MPN [156].